This study is the first preclinical pharmacokinetic study of BPC157, and the results are of considerable importance, as they demonstrate not only the pharmacokinetic parameters of BPC157 but also show the implications for its systemic application as a novel drug for various injuries
Research remains limited, and the effects of BPC-157 on blood pressure have not been fully established in large human studies
and it reduces oxidative stress in melanocytes, which is a key driver of hyperpigmentation
(2008) The x c cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases, J
Liposomal encapsulation protects glutathione from destruction by digestive enzymes, and the tiny particles of Quicksilver Scientific's advanced delivery system provide exceptionel absorption
No baseline documentation: without pre-protocol photography, patients lose their reference point